/PRNewswire/ Lightpoint Medical, a medical device company developing cancer detection tools for minimally-invasive and robot-assisted surgery, announced.
Lightpoint Medical Announces $8 Million in Funding to Support Commercial Launch of its Robotic Cancer Detection Probe finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Lightpoint Medical Receives CE Mark for World s First Approved Robotic Gamma Probe
News provided by
Share this article
Share this article
CHESHAM, England, Jan. 20, 2021 /PRNewswire/ Lightpoint Medical, a medical device company developing miniaturized surgical tools for advanced intra-operative cancer detection, announced today that it has received CE Mark approval for SENSEI®, the first robotic gamma probe to be commercially available to European hospital systems.
Lightpoint Medical Receives CE Mark for World’s First Approved Robotic Gamma Probe
SENSEI® has been designed for intra-operative detection of sentinel lymph nodes as well as cancer metastasis through the lymphatic system. The technology promises more precise, targeted cancer surgery and is applicable across a wide range of major cancer types, including lung, colorectal, stomach, gynecological, and prostate cancer.